Thomas Abel, MD | UniHealth

Offices

4 locations · Regents of the Univ of CA · 1,571 clinicians in this group

Looking this up.

Hospitals listed: University of California Davis Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Abel’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence G29287 · Current

Licensed to practise in California · since 1975 · expires 2027-04-30 · Mcgill University Faculty of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

University of California Davis Medical CenterSacramento, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UC Davis Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 74% would definitely recommend it
Overall rating: 4 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 1.94 (1.18 to 2.71) · 3,010 cases, Jul 2022 – Jun 2024Worse than the national rate — MRSA Bacteremia: 1.564, Oct 2024 – Sep 2025Worse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 6.7 (5.6 to 8) · 1,134 cases, Jan 2024 – Dec 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.6 (10.9 to 14.5) · 1,134 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 127.46 (95.81 to 159.1) · 281 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.18 (0 to 0.57) · 12,625 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.677, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.713, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,436 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for University of California Davis Medical Center

Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 1 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at University of California Davis Medical Center

Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.94 (1.18 to 2.71) · 3,010 cases	Worse	Jul 2022 – Jun 2024
MRSA BacteremiaInfections	1.564	Worse	Oct 2024 – Sep 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	6.7 (5.6 to 8) · 1,134 cases	Worse	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	12.6 (10.9 to 14.5) · 1,134 cases	Worse	Jan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	127.46 (95.81 to 159.1) · 281 cases	Better	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.18 (0 to 0.57) · 12,625 cases	Better	Jul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.677	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.713	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.8 (0.7 to 1) · 2,436 cases	Better	Jan 2024 – Dec 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.98 (0.78 to 1.19)	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.2 · 82 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.2 · 165 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	11.2 · 115 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	9.7 · 662 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.1 · 463 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	10.1 · 406 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.9 · 4,328 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.22 (0.05 to 0.39) · 13,828 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.3 (0.13 to 0.46) · 14,152 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	4.29 (2.92 to 5.66) · 4,920 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	1.78 (0.46 to 3.09) · 2,250 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.07 (1.06 to 3.09) · 4,696 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	9.46 (5.18 to 13.75) · 2,102 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	6.35 (3.74 to 8.96) · 2,191 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	2.48 (1.19 to 3.77) · 1,169 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	4.3 · 127 cases	None	Apr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.826	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.899	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.669	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	14.2 · 131 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	21.2 · 751 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	-25.8 · 127 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	24.1 · 758 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	23.6 · 477 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	17.6 · 469 cases	None	Jul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits	5.7 · 140 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	10.9 · 65 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	18.3 · 203 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	11.8 (9.4 to 14.9) · 2,643 cases	No different	Jan 2022 – Dec 2024

What patients said (2,768 patients answered, 18% of those asked)

Sort by

Patient survey stars by topic at University of California Davis Medical Center

Cleanliness	2
Nurse communication	3
Doctor communication	3
Communication about medicines	3
Discharge information	4
Overall hospital rating	3
Quietness	1
Recommend hospital	4

Sort by

Share of patients giving the best answer at University of California Davis Medical Center

Room was "always" clean	61%
Nurses "always" communicated well	76%
Doctors "always" communicated well	78%
Staff "always" explained	60%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	72%
Doctors "always" listened carefully	76%
Doctors "always" treated them with courtesy and respect	85%
Patients who gave a rating of "9" or "10" (high)	68%
Staff "always" explained new medications	73%
Nurses "always" explained things so they could understand	71%
Nurses "always" listened carefully	74%
Nurses "always" treated them with courtesy and respect	84%
"Always" quiet at night	37%
"YES", patients would definitely recommend the hospital	74%
Staff "always" explained possible side effects	47%
Yes, staff "did" give patients information about possible symptoms	89%

Original Medicare doctor bills

$3,831

Medicare paid this office $3,831 for 33 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	23	$2,072	$74
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	16	$215	$13

Who their Medicare patients are

33 Original Medicare patients in 2024. Average age 69 · Also on Medicaid 52% · Health risk score 2.15. Sicker patients than 9 in 10 peers; the typical rheumatology clinician is at 1.38.

Conditions among them: High blood pressure 75% · Diabetes 33%.

The office billed $24,299, Medicare allowed $5,037 and paid $3,831; for 61 services of 9 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	33	61	69	2.15	$24,299	$3,831
2023	37	58	70	2.11	$27,801	$4,717
2022	46	56	69	1.75	$27,724	$4,299
2021	21	24	67	1.52	$11,664	$2,197
2020	53	312	71	1.38	$26,685	$5,704
2019	203	972	72	1.40	$137,336	$38,212
2018	82	197	72	1.44	$37,378	$9,943
2017	177	562	73	1.34	$125,511	$34,546
2016	27	47	74	1.13	$12,486	$3,582
2015	90	127	68	1.55	$8,095	$4,103

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 1 service

Sort by

Original Medicare services billed in 2023

Return visit (30+ min)	21	$2,463	$79

2022: 1 service

Sort by

Original Medicare services billed in 2022

Return visit (30+ min)	28	$2,249	$66

2021: 1 service

Sort by

Original Medicare services billed in 2021

Return visit (30+ min)	13	$1,337	$84

2020: 1 service

Sort by

Original Medicare services billed in 2020

Short return visit (20+ min)	37	$740	$19

2019: 5 services

Sort by

Original Medicare services billed in 2019

Short return visit (20+ min)	118	$11,785	$60
New patient visit (45+ min)	70	$9,637	$138
Return visit (30+ min)	24	$3,126	$95
Aspiration and/or injection of fluid from large joint	26	$2,260	$65
Injection, methylprednisolone acetate, 80 mg	46	$683	None

2018: 4 services

Sort by

Original Medicare services billed in 2018

New patient visit (45+ min)	25	$3,584	$143
Short return visit (20+ min)	43	$2,540	$53
Return visit (30+ min)	11	$1,097	$91
Injection, methylprednisolone acetate, 80 mg	17	$194	None

2017: 9 services

Sort by

Original Medicare services billed in 2017

New patient visit (45+ min)	118	$15,558	$132
Short return visit (20+ min)	57	$5,367	$63
Aspiration and/or injection of fluid from large joint	27	$2,537	$53
New patient visit (30+ min)	21	$1,861	$89
Long return visit (40+ min)	12	$1,709	$122
Return visit (30+ min)	16	$1,672	$93
Aspiration and/or injection of fluid from medium joint	13	$664	$47
Injection, methylprednisolone acetate, 80 mg	22	$288	None
Injection, methylprednisolone acetate, 40 mg	17	$114	None

2015: 3 services

Sort by

Original Medicare services billed in 2015

New patient visit (45+ min)	12	$1,187	$99
Short return visit	53	$1,050	$19
Short return visit (20+ min)	12	$466	$39

Drugs they prescribed that Part D paid

$1,581

Pharmacies billed $1,581 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 73) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.

65 generic and fewer than 11 brand-name prescriptions · $1,581 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Allopurinol	13	$81	$6
Prednisone	11	$65	$6

Year by year

Sort by

Part D prescribing by year

2024	73	17	0% (0)	None	$1,581
2023	45	17	0% (0)	None	$10,447
2022	59	20	0% (0)	None	$44,142
2021	50	17	0% (0)	22%	$2,109
2020	575	124	None	23%	$517,697
2019	1,166	259	4% (46)	21%	$835,991
2018	367	121	None	22%	$282,189
2017	576	142	None	18%	$189,069
2016	378	143	None	32%	$115,572
2015	439	180	8% (34)	19%	$117,585
2014	745	268	5% (38)	None	$113,386
2013	1,675	424	8% (128)	None	$243,034

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2022: 1 drug

Sort by

Part D drugs prescribed in 2022

Prednisone	12	$223	$19

2021: 1 drug

Sort by

Part D drugs prescribed in 2021

Sulfasalazine	14	$415	$30

2020: 15 drugs

Sort by

Part D drugs prescribed in 2020

Enbrel Sureclick	17	$99,880	$5,875
Flector	11	$8,670	$788
Restasis	12	$8,195	$683
Clobetasol Propionate	16	$6,699	$419
Methotrexate	60	$4,943	$82
Hydroxychloroquine Sulfate	74	$4,228	$57
Cevimeline	18	$3,906	$217
Leflunomide	29	$2,625	$91
Sulfasalazine	22	$701	$32
Prednisone	50	$524	$10
Diclofenac	15	$469	$31
Allopurinol	27	$369	$14
Alendronate	32	$275	$9
Gabapentin	11	$267	$24
Meloxicam	18	$112	$6

2019: 27 drugs

Sort by

Part D drugs prescribed in 2019

Enbrel Sureclick	40	$207,973	$5,199
Humira	14	$112,527	$8,038
Humira(Cf)	17	$110,157	$6,480
Orencia	21	$96,835	$4,611
Humira(Cf)	13	$70,409	$5,416
Actemra	15	$64,201	$4,280
Xeljanz Xr	11	$59,150	$5,377
Hydroxychloroquine Sulfate	106	$17,390	$164
Restasis	18	$15,373	$854
Mycophenolate Mofetil	14	$10,925	$780
Colcrys	12	$9,381	$782
Methotrexate	152	$9,218	$61
Leflunomide	37	$8,099	$219
Colchicine	11	$3,266	$297
Cevimeline	13	$2,192	$169
Prednisone	204	$1,898	$9
Celecoxib	18	$1,417	$79
Risedronate	13	$1,048	$81
Allopurinol	34	$820	$24
Alendronate	56	$571	$10
Diclofenac	11	$453	$41
Gabapentin	32	$439	$14
Omeprazole	24	$389	$16
Hydrocodone-Acetaminophen	18	$349	$19
Sulfasalazine	12	$302	$25
Meloxicam	43	$225	$5
Tramadol	22	$216	$10

2018: 11 drugs

Sort by

Part D drugs prescribed in 2018

Humira	15	$72,705	$4,847
Enbrel Sureclick	14	$69,209	$4,944
Hydroxychloroquine Sulfate	28	$7,155	$256
Methotrexate	36	$4,747	$132
Etodolac	13	$695	$53
Prednisone	56	$591	$11
Diclofenac	14	$503	$36
Allopurinol	24	$393	$16
Alendronate	32	$239	$7
Levothyroxine	12	$134	$11
Meloxicam	11	$71	$6

2017: 14 drugs

Sort by

Part D drugs prescribed in 2017

Humira	17	$77,145	$4,538
Hydroxychloroquine Sulfate	48	$13,042	$272
Colchicine	19	$7,706	$406
Methotrexate	41	$5,356	$131
Leflunomide	20	$4,033	$202
Prednisone	128	$1,327	$10
Diclofenac	24	$957	$40
Etodolac	13	$787	$61
Voltaren	12	$736	$61
Allopurinol	38	$727	$19
Gabapentin	16	$322	$20
Nortriptyline	21	$286	$14
Alendronate	42	$254	$6
Meloxicam	27	$67	$2

2016: 8 drugs

Sort by

Part D drugs prescribed in 2016

Enbrel	18	$65,690	$3,649
Hydroxychloroquine Sulfate	28	$6,289	$225
Colchicine	12	$6,101	$508
Leflunomide	25	$5,042	$202
Methotrexate	73	$3,190	$44
Pilocarpine	17	$3,051	$179
Prednisone	120	$2,172	$18
Alendronate	11	$147	$13

2015: 11 drugs

Sort by

Part D drugs prescribed in 2015

Humira	15	$55,694	$3,713
Hydroxychloroquine Sulfate	36	$7,030	$195
Methotrexate	56	$4,963	$89
Leflunomide	28	$4,226	$151
Voltaren	14	$1,283	$92
Prednisone	47	$886	$19
Allopurinol	23	$840	$37
Nabumetone	12	$756	$63
Hydrocodone-Acetaminophen	17	$432	$25
Sulfasalazine	15	$396	$26
Tramadol	14	$128	$9

2014: 16 drugs

Sort by

Part D drugs prescribed in 2014

Enbrel	14	$30,623	$2,187
Humira	13	$26,194	$2,015
Methotrexate	108	$12,338	$114
Leflunomide	54	$5,662	$105
Colcrys	11	$4,057	$369
Hydroxychloroquine Sulfate	66	$2,969	$45
Prednisone	134	$2,799	$21
Pilocarpine	19	$2,735	$144
Azathioprine	23	$2,095	$91
Nabumetone	24	$1,123	$47
Sulfazine	13	$956	$74
Nifedipine Er	15	$954	$64
Allopurinol	33	$944	$29
Tramadol	18	$215	$12
Hydrocodone-Acetaminophen	13	$185	$14
Meloxicam	12	$121	$10

2013: 27 drugs

Sort by

Part D drugs prescribed in 2013

Enbrel	42	$86,403	$2,057
Humira	23	$45,408	$1,974
Methotrexate	242	$16,635	$69
Colcrys	24	$8,644	$360
Leflunomide	80	$7,705	$96
Pilocarpine	48	$7,152	$149
Hydroxychloroquine Sulfate	154	$7,085	$46
Prednisone	341	$5,961	$17
Celebrex	12	$4,994	$416
Azathioprine	52	$3,874	$75
Dulera	13	$2,955	$227
Allopurinol	63	$2,215	$35
Sulfazine	30	$2,109	$70
Voltaren	33	$2,040	$62
Methylprednisolone	13	$1,876	$144
Nabumetone	28	$1,372	$49
Nifedipine Er	22	$1,158	$53
Hydrocodone-Acetaminophen	57	$1,035	$18
Tramadol	60	$798	$13
Indomethacin	18	$531	$29
Dexamethasone	13	$397	$31
Alendronate	20	$395	$20
Naproxen	11	$297	$27
Meloxicam	23	$261	$11
Nortriptyline	21	$253	$12
Tizanidine	14	$244	$17
Ranitidine	11	$195	$18

Money from drug and device companies

$66 in 2021

Sort by

Industry payments by year

2021	1	1	None	$66
2020	2	2	None	$65
2019	2	2	None	$104

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Janssen Scientific Affairs	Tremfya	$66	1 payment Meals for Tremfya · 2021-07-30 · $66

See the published payment

Sort by

Every published payment

Janssen Scientific Affairs	Meals · 2021-07-30	Tremfya	$66

See earlier years (2020, 2019)

2020: $65

Sort by

Payments by company in 2020

Janssen Scientific Affairs	Simponi Aria	$47	1 payment Meals for Simponi Aria · 2020-01-21 · $47
Lombart Brothers	Opd-III	$18	1 payment Meals for Opd-III · 2020-01-29 · $18

2019: $104

Sort by

Payments by company in 2019

Janssen Scientific Affairs	Simponi Aria	$86	1 payment Meals for Simponi Aria · 2019-05-15 · $86
Marco Ophthalmic	Opd-III	$18	1 payment Meals for Opd-III · 2019-11-06 · $18

Professional record

NPI: 1871679399
Licence: CA G29287California G29287: Current · expires 2027-04-30
Group: Regents of the Univ of CA
Video visits: Lists video visits
Gender: Male

More record details

Sole proprietor: No
Medicaid ID: CA 00G292870
Taxonomy: Federal specialty code 207RR0500X (207RR0500X)
Mailing address: 1800 Harrison St Fl 7, Oakland, CA, 94612
NPI first listed: 2006-10-27
NPI last updated: 2014-10-23

This is when the NPI record was last certified, not a medical board exam.